Project Grant R34AA031020

Award Date 9/20/24
Completion Date 8/31/27
Dollars Obligated $331K
Federal Grant Program
93.273
Assistance Type
Project Grant
Place of Performance
Omaha, NE 68198, USA
Similar Awards
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $481,428 Project Grant under the Alcohol Research Programs (CFDA 93.273) to the Moses-Weitzman Health System, Inc. on September 20, 2024. The project, titled "Translating Research into Practice on Alcohol and Polysubstance Use Disorders by Educating the Interprofessional Primary Care Team," aims to improve the capacity of primary care providers in federally qualified health centers and other safety net settings to...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $220,656 Project Grant under the Alcohol Research Programs (CFDA 93.273) to the Board of Regents of the University of Nebraska, through its University of Nebraska Medical Center (UNMC) division. The grant will fund research to investigate the effects of ethanol metabolism on the sorting of non-isgylated HIV proteins to hepatocyte-derived exosomes, and how these exosomes impact the pro-fibrotic activation of hepatic stellate...
This $366,406 Project Grant was awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) to Yale University. The grant will be used to develop two novel human laboratory models to screen potential medications for Alcohol Use Disorder (AUD). The first model will assess a medication's ability to increase abstinence and reduce heavy drinking, which align with key FDA endpoints for AUD medication approval. The second model will...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $1,373,036 Project Grant under the Alcohol Research Programs (CFDA 93.273) to Yale University. The overarching goal of this 5-year research project (Sep 2024 - Aug 2029) is to enhance the understanding and prediction of heavy drinking episodes during initial recovery from alcohol use disorder (AUD). The project aims to leverage wearable biosensor technology and artificial intelligence to develop real-time predictive...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $736,668 Project Grant under the Alcohol Research Programs (CFDA 93.273) to the University of Southern California to conduct a multi-method investigation of social facilitation of alcohol effects and alcohol misuse in young adults. The project aims to extend prior research on the phenomenon of social facilitation of alcohol effects, exploring predisposing factors and mechanisms. This will involve laboratory-based studies...
This federal Project Grant award of $1,135,243 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will support research to investigate changes in neural mechanisms associated with cognitive reappraisal and alcohol cue reactivity during early abstinence from alcohol use disorder (AUD) treatment. The research, conducted by the University of Colorado-Denver and involving sub-awards to Emory University and the University of Denver,...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $537,587 Project Grant under the Alcohol Research Programs (CFDA 93.273) to The University of Texas Southwestern Medical Center to conduct research on the metabolic consequences of liver inflammation on alcohol consumption and alcohol-associated liver disease (ALD). The key objectives are to identify the mechanisms by which the transcription factor IRF3 suppresses the expression and secretion of the metabolic regulator...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a Project Grant under the Alcohol Research Programs (CFDA 93.273) to the University of Illinois. The $293,128 grant, awarded on August 23, 2024, will fund a study examining the neural correlates of alcohol reward in social contexts using a hyperscanning EEG setup. The research aims to evaluate the neural mechanisms underlying the rewarding effects of alcohol in social settings and assess how individual and group-level factors...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $1,547,718 Project Grant under the Alcohol Research Programs (CFDA 93.273) to the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) from September 1, 2024 to May 31, 2029. The project will investigate the role of KDM5 demethylases in regulating cell-cell communication in the development and resolution of alcohol-associated liver disease. Specifically, the research aims to determine how KDM5B and KDM5C...
This $499,987 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will fund the development of a High Throughput Alcohol Screening Platform (HT-ASP) that incorporates cortical organoids. The project aims to create an automated platform to mature, maintain, and assay over 100 organoids in culture, providing a robust and genetically diverse system for screening potential alcohol use disorder therapeutics. The...

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $330,829 Project Grant under the Alcohol Research Programs (CFDA 93.273) to the Board of Regents of the University of Nebraska, University of Nebraska Medical Center (UNMC) Division. The grant, titled "Leveraging Alcohol Use Disorder Screening for Treatment in Routine Perioperative Care: ALLUSCARE", aims to leverage existing electronic health record-integrated alcohol screening tools to increase the provision of alcohol use disorder (AUD)-specific care for surgical patients. The project involves a two-center prospective observational cohort study to assess patient acceptability, feasibility of data collection, and optimal outcome measures for a future pragmatic trial. The grant will also optimize AUD intervention bundles most likely to be effective in a future pragmatic randomized trial, with a focus on health equity. UNMC has established sub-awards with the University of Michigan, University of Texas Health Science Center at Houston, and Sporedata Inc. to support various aspects of the research project.

Generated 7/1/25, 3:12 AM